A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor – 25I-NBOMe / Daria Schetz, Adriana Schetz, Ivan Kocić.
Publikacja dostępna w open access na licencji CC BY 4.0.
Received 21 August 2021, revised 30 September 2021, accepted 5 October 2021, available online 1 January 2022.
The data that support the findings of this study are available from the corresponding author upon reasonable request.
CRediT authorship contribution statement: Daria Schetz: conceptualization, methodology, formal analysis, resources, writing – original draft, writing – review & editing, visualization, project administration, Adriana Schetz: conceptualization, methodology, writing – review & editing, Ivan Kocić: methodology, writing – review & editing, project administration..
agonist of 5-HT2A25I-NBOMe
hallucinogen persisting perception disorder
novel psychoactive substances